PALO ALTO, California, July 2, 2018 /PRNewswire/ -- ReCor Medical announced today that the US Food & Drug Administration approved the Company's new pivotal study of the Paradise Ultrasound Denervation System for the treatment of hypertension: RADIANCE-II. Building upon the recent...
from PR Newswire: //https://ift.tt/2MBoVqn
No comments:
Post a Comment